3Mollison PL. Blood transfusion in clinical medicine.9th ed. Oxford Blackwell Scientific Publication, 1993.166-167
4Dodd BE,Lincoln PJ, Boorman KE.The cross-reacting antibodies of group O sera: Immunological studies and possible explanation of the observed facts. Immunology,1967,12:39
5Mollison P L. et al. Blood Transfusion in Clinical Medicine. 9th ed. Oxford Blackwell. Scientific Publication, 1993, 166-167.
6Garner SF, Corick BD, Lai WY, et al. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results. Vox Sang, 1995, 68(3) :169-176.
7Downing I,Bromilow IM ,Templeton JG. A retrospective study of red cell maternal antibodies by chemiluminescence. Vox Sang, 1996,71 (4) :226- 232.
8Iyer YS , Kulkarni SV,Gupte SC. Distribution of IgGsubtypes in maternal anti-D sera and their prognostic value in Rh haemolytic disease of the newborn. Acta Haematol, 1992,88 ( 2-3 ) :78-81.
9Leger RM. In vitro cellular assays and other approaches used to predict the clinical significance of red cell alloantibodies: a review. Immunohematol, 2002,18(3) :65-70.
